Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Drug Pricing topic

No spam. Unsubscribe anytime.

Presenter announces addition of 160 drugs to price-check site, expanding coverage to about four in five prescriptions

AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

A presenter said 160 more drugs will be added to a price-comparison site, bringing listings to "over 750" and, the presenter said, enabling roughly four out of five medications picked up at the same drugstore to be checked for the best price. The transcript does not identify the site, agency, or timeline.

A presenter announced that 160 more drugs will be added to an online price-comparison site, saying the addition will raise the site's total to "over 750" listed drugs and broaden consumer ability to check prices.

The presenter said, "we are adding 160 more drugs to this site. Now, this site already has 700 or so or 600 or so drugs, so it's going to take it over 750 total." They added that "four out of five medications that are picked up by Americans going into that same drugstore... now have the opportunity to double-check that the price they're getting in that drugstore or wherever they're buying it from is the best price out there." The transcript records the speaker's numbers in uncertain terms ("700 or so or 600 or so").

The announcement did not identify the name of the site, the agency or organization operating it, the timeline for when the additional drug listings will go live, or the data sources and methodology used to match drug prices across retailers. No follow-up questions or additional details were recorded in the provided transcript.

Because the transcript records the speaker's phrasing as approximate, the article notes the uncertainty in the counts: the presenter stated "700 or so or 600 or so," said the total will be "over 750," and characterized the coverage as affecting "four out of five" medications. Those figures were presented by the presenter but were not accompanied by supporting documentation or a named authority in the transcript.

The record contains no formal action, motion, or vote connected to the announcement, and no named official or agency was identified in the excerpt provided. The presenter did not specify next procedural steps or a contact for verification.